FT
This pharmaceutical company develops and commercializes novel, local therapies for musculoskeletal conditions, starting with osteoarthritis. Their products aim to enhance the clinical effect of intra-articular corticosteroid treatment for patients.
Updated 2 months ago
Funding
$30M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This pharmaceutical company develops and commercializes novel, local therapies for musculoskeletal conditions, starting with osteoarthritis. Their products aim to enhance the clinical effect of intra-articular corticosteroid treatment for patients.